CD

Craig A. Dunbar

TT Tarveda Therapeutics: 4 patents #7 of 19Top 40%
PT Placon Therapeutics: 2 patents #8 of 19Top 45%
VI Vertex Pharmaceuticals Incorporated: 2 patents #526 of 896Top 60%
📍 Needham, MA: #169 of 796 inventorsTop 25%
🗺 Massachusetts: #14,132 of 88,656 inventorsTop 20%
Overall (All Time): #557,728 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11458206 Targeted conjugates and particles and formulations thereof Rossitza G. Alargova, Mark T. Bilodeau, Sudhakar Kadiyala, Rajesh R. Shinde, Patrick Lim Soo +4 more 2022-10-04
10624967 Targeted conjugates and particles and formulations thereof Rossitza G. Alargova, Mark T. Bilodeau, Sudhakar Kadiyala, Rajesh R. Shinde, Patrick Lim Soo +4 more 2020-04-21
10322191 Targeted conjugates and particles and formulations thereof Rossitza G. Alargova, Mark T. Bilodeau, Sudhakar Kadiyala, Rajesh R. Shinde, Patrick Lim Soo +4 more 2019-06-18
10111853 Compounds, compositions, and methods for the treatment of cancers Mark T. Bilodeau, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danielle N. Rockwood +3 more 2018-10-30
10058546 Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxo1-5-y1)-N-(1-(2,3-dihydroxypropy1)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-y1)-1H-indol-5-y1) cyclopropanecarbox-amide and administration thereof Rossitza Gueorguieva Alargova, Irina Nikolaevna Kadiyala 2018-08-28
9750818 Targeted conjugates and particles and formulations thereof Rossitza G. Alargova, Mark T. Bilodeau, Sudhakar Kadiyala, Rajesh R. Shinde, Patrick Lim Soo +4 more 2017-09-05
9556214 Compounds, compositions, and methods for the treatment of cancers Mark T. Bilodeau, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danille N. Rockwood +3 more 2017-01-31
9480657 Cabazitaxel-platinum nanoparticles and methods of using same Mark T. Bilodeau, Timothy E. Barder, Edward R. Lee, Rossitza G. Alargova, Danielle N. Rockwood 2016-11-01
9012496 Pharmaceutical compositions of (R)-1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide and administration thereof Rossitza Gueorguieva Alargova, Irina Nikolaevna Kadiyala 2015-04-21